Novartis Ag (NVSEF) Operating Income Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Operating Income Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 15.64%
Jun 30, 2024 8.55%
Dec 31, 2023 87.04%
Jun 30, 2023 2.48%
Mar 31, 2023 -4.85%
Dec 31, 2022 -2.19%
Sep 30, 2022 -0.68%
Jun 30, 2022 -0.46%
Mar 31, 2022 2.81%
Dec 31, 2021 -44.80%
Sep 30, 2021 4.45%
Jun 30, 2021 55.72%
Mar 31, 2021 1,452.44%
Dec 31, 2020 11.49%
Sep 30, 2020 25,108.85%
Jun 30, 2020 2,324.08%
Mar 31, 2020 -957.66%
Jun 30, 2019 2,141.15%
Mar 31, 2019 1,222.82%
Dec 31, 2018 1,437.33%